BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Fish and Richardson
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061454

« Back to Dashboard

NDA 061454 describes DICLOXACILLIN SODIUM, which is a drug marketed by Sandoz, Teva, and Apothecon, and is included in three NDAs. It is available from sixteen suppliers. Additional details are available on the DICLOXACILLIN SODIUM profile page.

The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.

Summary for 061454

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 061454


Medical Subject Heading (MeSH) Categories for 061454

Suppliers and Packaging for NDA: 061454

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DICLOXACILLIN SODIUM dicloxacillin sodium CAPSULE;ORAL 061454 ANDA Liberty Pharmaceuticals, Inc. 0440-1380 0440-1380-40 40 CAPSULE in 1 BOTTLE, PLASTIC (0440-1380-40)
DICLOXACILLIN SODIUM dicloxacillin sodium CAPSULE;ORAL 061454 ANDA Sandoz Inc 0781-2248 0781-2248-01 100 CAPSULE in 1 BOTTLE (0781-2248-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 250MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 125MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 500MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: